Exact Sciences Corp. (EXAS) Social Stream
EXACT SCIENCES CORP (EXAS) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering EXAS.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-04 | 12 | $165 | $95 | $143.583 | $67.45 | 112.87% |
| 2021-12-08 | 13 | $163 | $95 | $140.25 | $67.45 | 107.93% |
| 2022-01-04 | 13 | $163 | $95 | $139.25 | $67.45 | 106.45% |
| 2022-01-06 | 13 | $163 | $95 | $138 | $67.45 | 104.6% |
| 2022-01-18 | 13 | $163 | $95 | $136.5 | $67.45 | 102.37% |
| 2022-02-23 | 12 | $160 | $90 | $130.454 | $67.45 | 93.41% |
| 2022-02-24 | 12 | $160 | $90 | $125 | $67.45 | 85.32% |
| 2022-04-26 | 12 | $160 | $90 | $124.09 | $67.45 | 83.97% |
| 2022-04-28 | 12 | $160 | $65 | $104.714 | $67.45 | 55.25% |
| 2022-06-03 | 12 | $160 | $50 | $98.4 | $67.45 | 45.89% |
| 2022-07-19 | 11 | $160 | $50 | $89.571 | $67.45 | 32.8% |
| 2022-08-03 | 12 | $95 | $50 | $79.083 | $67.45 | 17.25% |
| 2022-08-13 | 13 | $95 | $50 | $71.307 | $67.45 | 5.72% |
| 2022-09-17 | 13 | $95 | $40 | $70.538 | $67.45 | 4.58% |
| 2022-10-17 | 13 | $95 | $40 | $69 | $67.45 | 2.3% |
| 2022-10-24 | 13 | $95 | $40 | $69.75 | $67.45 | 3.41% |
| 2022-11-04 | 13 | $85 | $40 | $67.454 | $67.45 | 0.01% |
| 2022-11-07 | 13 | $85 | $35 | $63.545 | $67.45 | -5.79% |
| 2022-11-08 | 13 | $85 | $35 | $62.636 | $67.45 | -7.14% |
| 2022-11-14 | 13 | $85 | $35 | $63.545 | $67.45 | -5.79% |
| 2022-12-04 | 13 | $85 | $35 | $61.09 | $67.45 | -9.43% |
| 2022-12-15 | 12 | $85 | $35 | $61.09 | $67.45 | -9.43% |
| 2023-01-06 | 12 | $85 | $35 | $62.545 | $67.45 | -7.27% |
| 2023-01-12 | 12 | $85 | $35 | $61.416 | $67.45 | -8.95% |
| 2023-01-26 | 12 | $85 | $35 | $63.181 | $67.45 | -6.33% |
The Trend in the Analyst Price Target
EXAS's average price target has moved down $37.29 over the prior 33 months.
EXAS reports an average of 61.18% for its upside potential over the past 48 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-07-19 | 11 | 95 | 50 | 79.083 | 46.82 | 68.91% |
| 2022-07-19 | 9 | 95 | 50 | 79.083 | 46.82 | 68.91% |
| 2022-11-14 | 13 | 85 | 35 | 63.545 | 44.81 | 41.81% |
| 2023-01-12 | 12 | 85 | 35 | 61.416 | 68.54 | -10.39% |
| 2023-01-25 | 12 | 85 | 35 | 63.181 | 64.25 | -1.66% |
EXAS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.67 | 8 | 0 | 4 | 0 | 0 | 12 |
The Trend in the Broker Recommendations
Over the past 153 days, EXAS's average broker recommendation rating worsened by 0.29.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- EXACT SCIENCES CORP's upside potential (average analyst target price relative to current price) is higher than 1516.36% of all US stocks.
- EXAS has a higher number of analysts covering the stock than 2748.48% of Healthcare stocks.
- In terms of how EXACT SCIENCES CORP fares relative to Healthcare stocks, note that its average analyst price target is greater than 2568.05% of that group.
- To contextualize these metrics, consider that out of stocks in the large market cap category, EXACT SCIENCES CORP's variance in analysts' estimates is lower than -2379.58% of them.
Stocks similar to EXACT SCIENCES CORP in the Business Services industry regarding analyst recommendations and price targets are CRL, INCY, and ALLE.
View All Top Stocks by Price Target
Make investment decisions regarding EXAS using the data that counts. Try POWR Ratings for free.